Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas
伊布替尼联合纳武利尤单抗治疗复发性中枢神经系统淋巴瘤患者的二期临床试验
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024014635
Chihara, Dai; Steiner, Raphael E; Nair, Ranjit; Feng, Lei; Ahmed, Sairah; Strati, Paolo; Malpica, Luis; Griffith, Donna P; Mathew, Shivon A; Montinez, Wirt; Masand, Gita; Samaniego, Felipe; Rodriguez, Maria A; Hagemeister, Fredrick B; Fayad, Luis E; Iyer, Swaminathan P; Nastoupil, Loretta J; Neelapu, Sattva S; Flowers, Christopher R; Westin, Jason R